SELLAS Life Sciences Group Expands EnterOne's IT Training Reach in Latin America
- EnterOne acquires SLS LATAM Argentina and Chile to enhance IT training offerings in Latin America.
- The acquisition strengthens EnterOne's position in Cisco training programs and expands educational resources for IT professionals.
- EnterOne aims to further extend operations into Paraguay and Uruguay, enhancing its impact on regional IT education.
EnterOne Expands Training Footprint in Latin America through Strategic Acquisition
EnterOne, a leading company in IT training and services, makes a significant move in the Latin American market by acquiring SLS LATAM Argentina and SLS LATAM Chile, both of which are esteemed Cisco Learning Partners. This acquisition, announced on March 7, 2025, strengthens EnterOne's position within the Cisco MINT (Mentored Install Network Training) and DSI (Digital Solutions Integrator) programs. With over 15 years of experience, SLS LATAM is known for providing high-quality Cisco training and specialized consulting, earning a reputable standing among IT professionals throughout the region. The acquisition allows EnterOne to broaden its educational offerings and cater to the growing needs of the IT workforce in Latin America.
The integration of EnterOne’s comprehensive educational catalog into SLS LATAM’s existing framework significantly enhances the training solutions available in the region. The combined entity will offer access to thousands of courses and certifications, partnering with major suppliers such as Microsoft, AWS, F5, and VMware. This diverse range of educational resources not only enriches the training landscape but also positions EnterOne as a competitive player in IT education. According to Anthony Hamilton, CEO of EnterOne, the acquisition is pivotal to the company's mission of expanding its global reach and delivering exceptional training solutions tailored to the digital transformation needs of professionals in emerging markets.
Looking ahead, EnterOne plans to leverage this acquisition to extend its operations into Paraguay, Uruguay, and other South American countries, thereby broadening its impact on the region's IT education landscape. Matías Villaverde, Key Leader of SLS LATAM, underscores the excitement surrounding the strengthened portfolio, which aims to meet the increasing demands of IT professionals. This strategic move not only showcases EnterOne's commitment to professional development and digital transformation but also positions the combined forces of the two companies as a formidable entity in empowering Latin America's workforce to thrive in a competitive global marketplace.
In addition to expanding its training offerings, EnterOne is recognized for its innovative solutions across various technological domains, including artificial intelligence, cloud computing, and cybersecurity. By focusing on these emerging fields, the company aims to equip professionals with the skills needed to navigate the rapidly evolving digital landscape. This acquisition marks a strategic milestone for EnterOne as it continues to prioritize professional education and workforce development in the region.
The acquisition of SLS LATAM is more than just a business transaction; it reflects a strategic vision aimed at fostering growth and innovation in Latin America's IT sector. As EnterOne integrates these new assets, the company sets the stage for a transformative impact on the future of IT training and consulting in the region.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

